Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China
· Delayed Price · Currency is CNY 27.85
+0.24 (0.87%)
Apr 29, 2026, 3:04 PM CST
SHE:300204 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 128.28 | 123.64 | 53.91 | 85.18 | 264.99 | 85.01 | Upgrade
|
| Trading Asset Securities | - | - | - | - | - | 381.46 | Upgrade
|
| Cash & Short-Term Investments | 128.28 | 123.64 | 53.91 | 85.18 | 264.99 | 466.47 | Upgrade
|
| Cash Growth | 43.43% | 129.34% | -36.71% | -67.86% | -43.19% | -35.44% | Upgrade
|
| Accounts Receivable | 46.74 | 41.52 | 39.07 | 61.22 | 188.18 | 157.9 | Upgrade
|
| Other Receivables | 0.89 | 1.22 | 0.64 | 1.14 | 1.38 | 1.18 | Upgrade
|
| Receivables | 47.64 | 42.75 | 39.72 | 62.35 | 189.56 | 159.07 | Upgrade
|
| Inventory | 19.55 | 19.3 | 22.18 | 20.93 | 18.83 | 25.01 | Upgrade
|
| Prepaid Expenses | - | - | 0.01 | 0.01 | - | - | Upgrade
|
| Other Current Assets | 66.95 | 66.97 | 61.8 | 70.41 | 55.69 | 37.9 | Upgrade
|
| Total Current Assets | 262.42 | 252.65 | 177.62 | 238.89 | 529.06 | 688.44 | Upgrade
|
| Property, Plant & Equipment | 205.99 | 211.79 | 235 | 261.36 | 290.58 | 312.43 | Upgrade
|
| Long-Term Investments | 471.64 | 475.02 | 514.07 | 549.54 | 522.25 | 545.43 | Upgrade
|
| Goodwill | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 22.17 | Upgrade
|
| Other Intangible Assets | 36.16 | 36.36 | 34.67 | 35.13 | 80.48 | 82.22 | Upgrade
|
| Long-Term Deferred Tax Assets | 50.42 | 50.42 | 50.08 | 164 | 198.13 | 155.84 | Upgrade
|
| Long-Term Deferred Charges | 201.4 | 186.77 | 117.84 | 62.57 | 26.97 | 5.29 | Upgrade
|
| Other Long-Term Assets | 33.21 | 33.45 | 0.58 | 0.98 | 2.09 | 15.15 | Upgrade
|
| Total Assets | 1,281 | 1,266 | 1,150 | 1,332 | 1,669 | 1,827 | Upgrade
|
| Accounts Payable | 14.69 | 21.92 | 33.49 | 72.91 | 35.87 | 31.71 | Upgrade
|
| Accrued Expenses | 20.46 | 20.51 | 67.71 | 83.85 | 158.73 | 150.01 | Upgrade
|
| Short-Term Debt | 50.03 | 80.06 | 42.42 | 40.95 | 23.09 | - | Upgrade
|
| Current Portion of Long-Term Debt | 0.27 | 0.43 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 0.06 | - | 2.69 | 2.25 | Upgrade
|
| Current Income Taxes Payable | 3.05 | 1.05 | - | - | 0.02 | - | Upgrade
|
| Current Unearned Revenue | 1.19 | 1.26 | 3.89 | 2.86 | 3.27 | 1.34 | Upgrade
|
| Other Current Liabilities | 41.42 | 50.32 | 6.88 | 7.6 | 8.1 | 11.33 | Upgrade
|
| Total Current Liabilities | 131.1 | 175.55 | 154.45 | 208.17 | 231.77 | 196.64 | Upgrade
|
| Long-Term Leases | 0.58 | 0.67 | 0.06 | - | 3.18 | 5.37 | Upgrade
|
| Long-Term Unearned Revenue | 26.02 | 26.76 | 29.91 | 29.24 | 33.47 | 21.32 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 49.24 | 49.24 | 48.43 | 74.14 | 47.03 | 52.91 | Upgrade
|
| Other Long-Term Liabilities | 210.23 | 207.27 | - | - | - | - | Upgrade
|
| Total Liabilities | 486.07 | 459.48 | 232.85 | 311.55 | 315.45 | 276.25 | Upgrade
|
| Common Stock | 477.77 | 477.77 | 477.77 | 477.77 | 475.36 | 476.03 | Upgrade
|
| Additional Paid-In Capital | 558.6 | 558.6 | 570.95 | 534.46 | 519.36 | 536.44 | Upgrade
|
| Retained Earnings | -335.56 | -327.12 | -249.37 | -83.63 | 314.62 | 510.98 | Upgrade
|
| Treasury Stock | - | - | - | - | - | -43.68 | Upgrade
|
| Comprehensive Income & Other | 109.01 | 111.53 | 129.88 | 92.06 | 44.53 | 70.97 | Upgrade
|
| Total Common Equity | 809.82 | 820.78 | 929.23 | 1,021 | 1,354 | 1,551 | Upgrade
|
| Minority Interest | -14.91 | -14.06 | -12.47 | - | - | - | Upgrade
|
| Shareholders' Equity | 794.92 | 806.72 | 916.76 | 1,021 | 1,354 | 1,551 | Upgrade
|
| Total Liabilities & Equity | 1,281 | 1,266 | 1,150 | 1,332 | 1,669 | 1,827 | Upgrade
|
| Total Debt | 119.78 | 81.16 | 42.54 | 40.95 | 28.96 | 7.63 | Upgrade
|
| Net Cash (Debt) | 8.51 | 42.48 | 11.37 | 44.23 | 236.03 | 458.84 | Upgrade
|
| Net Cash Growth | -87.74% | 273.53% | -74.28% | -81.26% | -48.56% | -31.98% | Upgrade
|
| Net Cash Per Share | 0.02 | 0.09 | 0.02 | 0.09 | 0.49 | 0.97 | Upgrade
|
| Filing Date Shares Outstanding | 421.59 | 409.61 | 477.77 | 477.77 | 475.36 | 472.66 | Upgrade
|
| Total Common Shares Outstanding | 421.59 | 409.61 | 477.77 | 477.77 | 475.36 | 472.66 | Upgrade
|
| Working Capital | 131.32 | 77.1 | 23.18 | 30.72 | 297.28 | 491.8 | Upgrade
|
| Book Value Per Share | 1.92 | 2.00 | 1.94 | 2.14 | 2.85 | 3.28 | Upgrade
|
| Tangible Book Value | 753.91 | 764.67 | 874.81 | 965.78 | 1,254 | 1,446 | Upgrade
|
| Tangible Book Value Per Share | 1.79 | 1.87 | 1.83 | 2.02 | 2.64 | 3.06 | Upgrade
|
| Buildings | - | - | 215.93 | 214.75 | 184.57 | 183.64 | Upgrade
|
| Machinery | - | - | 317.62 | 318.38 | 254.98 | 246.28 | Upgrade
|
| Construction In Progress | - | - | - | - | 87.82 | 85.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.